Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage

Warren Ross, Bonnie Glisson, Jack Yalowich, Tom Rowe, Leroy-Fong Liu

Research output: Contribution to journalArticle

432 Citations (Scopus)

Abstract

Epipodophyllotoxins are an important new dass of anticancer agents which include the compounds VM-26 (teniposide) and VP-16 (etoposide).The mechanism of action of these drugs appears to involve production of DNA single- and double-strand breaks by virtue of a temperature-sensitive interaction between drug and a heat-labile intranuclear component. We now report evidence indicating that type II topoisomerase is the likely intracellular target for the DNA strand-breaking effects of the epipodophyllotoxins. Both VM-26 and VP-16 stimulate site-specific DNA cleavage by a highly purified calf thymus type II topoisomerase. VM-26 is 5- to 10-fold more potent than VP-16 in this assay, a difference that is also seen when DNA strand breaks are assayed in isolated nuclei of mouse leukemia cells following drug exposure. Furthermore, a similar potency difference exists with respect to cytotoxicity. Equilibrium dialysis experiments using [3H]VP-16 indicate that the drug does not bind to DNA. Thus, we suggest that the epipodophyllotoxins exert their anticancer effects by ‘poisoning’ type II topoisomerase without binding to DNA. In this regard, their actions may be analogous to those of nalidixic acid in bacteria.

Original languageEnglish
Pages (from-to)5857-5860
Number of pages4
JournalCancer Research
Volume44
Publication statusPublished - Dec 1 1984
Externally publishedYes

Fingerprint

Podophyllotoxin
Type II DNA Topoisomerase
DNA Cleavage
Teniposide
Etoposide
DNA
Pharmaceutical Preparations
Single-Stranded DNA Breaks
Nalidixic Acid
DNA Breaks
Double-Stranded DNA Breaks
Drug Interactions
Antineoplastic Agents
Poisoning
Thymus Gland
Dialysis
Leukemia
Hot Temperature
Bacteria
Temperature

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ross, W., Glisson, B., Yalowich, J., Rowe, T., & Liu, L-F. (1984). Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage. Cancer Research, 44, 5857-5860.

Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage. / Ross, Warren; Glisson, Bonnie; Yalowich, Jack; Rowe, Tom; Liu, Leroy-Fong.

In: Cancer Research, Vol. 44, 01.12.1984, p. 5857-5860.

Research output: Contribution to journalArticle

Ross, W, Glisson, B, Yalowich, J, Rowe, T & Liu, L-F 1984, 'Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage', Cancer Research, vol. 44, pp. 5857-5860.
Ross, Warren ; Glisson, Bonnie ; Yalowich, Jack ; Rowe, Tom ; Liu, Leroy-Fong. / Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage. In: Cancer Research. 1984 ; Vol. 44. pp. 5857-5860.
@article{c333bec2f24e4ee0b3ef73084ecef4fc,
title = "Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage",
abstract = "Epipodophyllotoxins are an important new dass of anticancer agents which include the compounds VM-26 (teniposide) and VP-16 (etoposide).The mechanism of action of these drugs appears to involve production of DNA single- and double-strand breaks by virtue of a temperature-sensitive interaction between drug and a heat-labile intranuclear component. We now report evidence indicating that type II topoisomerase is the likely intracellular target for the DNA strand-breaking effects of the epipodophyllotoxins. Both VM-26 and VP-16 stimulate site-specific DNA cleavage by a highly purified calf thymus type II topoisomerase. VM-26 is 5- to 10-fold more potent than VP-16 in this assay, a difference that is also seen when DNA strand breaks are assayed in isolated nuclei of mouse leukemia cells following drug exposure. Furthermore, a similar potency difference exists with respect to cytotoxicity. Equilibrium dialysis experiments using [3H]VP-16 indicate that the drug does not bind to DNA. Thus, we suggest that the epipodophyllotoxins exert their anticancer effects by ‘poisoning’ type II topoisomerase without binding to DNA. In this regard, their actions may be analogous to those of nalidixic acid in bacteria.",
author = "Warren Ross and Bonnie Glisson and Jack Yalowich and Tom Rowe and Leroy-Fong Liu",
year = "1984",
month = "12",
day = "1",
language = "English",
volume = "44",
pages = "5857--5860",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Role of Topoisomerase II in Mediating Epipodophyllotoxin-induced DNA Cleavage

AU - Ross, Warren

AU - Glisson, Bonnie

AU - Yalowich, Jack

AU - Rowe, Tom

AU - Liu, Leroy-Fong

PY - 1984/12/1

Y1 - 1984/12/1

N2 - Epipodophyllotoxins are an important new dass of anticancer agents which include the compounds VM-26 (teniposide) and VP-16 (etoposide).The mechanism of action of these drugs appears to involve production of DNA single- and double-strand breaks by virtue of a temperature-sensitive interaction between drug and a heat-labile intranuclear component. We now report evidence indicating that type II topoisomerase is the likely intracellular target for the DNA strand-breaking effects of the epipodophyllotoxins. Both VM-26 and VP-16 stimulate site-specific DNA cleavage by a highly purified calf thymus type II topoisomerase. VM-26 is 5- to 10-fold more potent than VP-16 in this assay, a difference that is also seen when DNA strand breaks are assayed in isolated nuclei of mouse leukemia cells following drug exposure. Furthermore, a similar potency difference exists with respect to cytotoxicity. Equilibrium dialysis experiments using [3H]VP-16 indicate that the drug does not bind to DNA. Thus, we suggest that the epipodophyllotoxins exert their anticancer effects by ‘poisoning’ type II topoisomerase without binding to DNA. In this regard, their actions may be analogous to those of nalidixic acid in bacteria.

AB - Epipodophyllotoxins are an important new dass of anticancer agents which include the compounds VM-26 (teniposide) and VP-16 (etoposide).The mechanism of action of these drugs appears to involve production of DNA single- and double-strand breaks by virtue of a temperature-sensitive interaction between drug and a heat-labile intranuclear component. We now report evidence indicating that type II topoisomerase is the likely intracellular target for the DNA strand-breaking effects of the epipodophyllotoxins. Both VM-26 and VP-16 stimulate site-specific DNA cleavage by a highly purified calf thymus type II topoisomerase. VM-26 is 5- to 10-fold more potent than VP-16 in this assay, a difference that is also seen when DNA strand breaks are assayed in isolated nuclei of mouse leukemia cells following drug exposure. Furthermore, a similar potency difference exists with respect to cytotoxicity. Equilibrium dialysis experiments using [3H]VP-16 indicate that the drug does not bind to DNA. Thus, we suggest that the epipodophyllotoxins exert their anticancer effects by ‘poisoning’ type II topoisomerase without binding to DNA. In this regard, their actions may be analogous to those of nalidixic acid in bacteria.

UR - http://www.scopus.com/inward/record.url?scp=0021688805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021688805&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 5857

EP - 5860

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

ER -